1 active not recruiting, 1 not yet recruiting. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Romosozumab Prefilled Syringe [Evenity]: new trials by email Literature Review of Romosozumab Prefilled Syringe [Evenity] trials Research Report on Romosozumab Prefilled Syringe [Evenity]
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures Romosozumab and Denosumab Combination Therapy, Romosozumab Prefilled Syringe [Evenity], Denosumab (Prolia) - Osteoporosis in Post-menopausal Women | Phase 4 | Not yet recruiting | Marmara University | 60 | 2025-01-15 | 2024-12-27 |
| Romosozumab/Denosumab Study for Premenopausal IOP Romosozumab Prefilled Syringe [Evenity], Denosumab 60 MG/ML Prefilled Syringe [Prolia] - Premenopausal Idiopathic Osteoporosis | Phase 2 | Active not recruiting | Columbia University | 30 | 2021-03-12 | 2026-02-27 |
Osteoporosis (1)
Columbia University (1) · Marmara University (1)
Turkey (Türkiye) (1) · United States (1)
Adi Cohen, MD (1) · Canan Sanal, Associate Profesor (1) · Elizabeth Shane, MD (1)